PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,884,245 | +5.5% | 704,700 | +68.0% | 0.01% | +16.7% |
| Q2 2023 | $5,577,448 | +20.3% | 419,357 | +4.7% | 0.01% | 0.0% |
| Q1 2023 | $4,636,308 | +54.6% | 400,372 | +9.2% | 0.01% | +50.0% |
| Q4 2022 | $2,998,608 | +82.6% | 366,578 | +25.0% | 0.00% | +100.0% |
| Q3 2022 | $1,642,000 | +96.4% | 293,210 | +55.1% | 0.00% | +100.0% |
| Q2 2022 | $836,000 | -65.8% | 189,058 | -29.6% | 0.00% | -50.0% |
| Q1 2022 | $2,445,000 | -49.7% | 268,658 | +13.2% | 0.00% | -50.0% |
| Q4 2021 | $4,858,000 | -18.3% | 237,435 | +2.0% | 0.00% | -33.3% |
| Q3 2021 | $5,947,000 | -19.1% | 232,769 | +1.8% | 0.01% | -14.3% |
| Q2 2021 | $7,348,000 | -1.9% | 228,552 | +1.6% | 0.01% | -12.5% |
| Q1 2021 | $7,493,000 | +48.3% | 224,954 | +15.5% | 0.01% | +33.3% |
| Q4 2020 | $5,051,000 | +335.1% | 194,727 | +65.5% | 0.01% | +200.0% |
| Q3 2020 | $1,161,000 | – | 117,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |